All In Biotech

Free tool

FAERS Monitor: Zidovudine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 200732 or its brand name (Zidovudine, Zidovudine). Reports on generic versions are filed under their own applications.

Reports

10,367

Serious

9,840

95% of reports

Hospitalization

2,189

Death reported

1,459

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • foetal exposure during pregnancy1,625
  • virologic failure778
  • drug resistance709
  • anaemia617
  • exposure during pregnancy588
  • pathogen resistance585
  • drug exposure during pregnancy580
  • viral mutation identified567
  • premature baby497
  • maternal exposure during pregnancy428
  • treatment failure420
  • lipodystrophy acquired413
  • death385
  • pyrexia372
  • drug ineffective341

Reports by year received

View as table
YearReports
2004342
2005319
2006479
2007447
2008445
2009480
2010459
2011347
2012282
2013298
2014344
2015534
20161,064
2017902
2018740
2019607
2020706
2021405
2022359
2023357
2024174
2025136
2026139

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,792 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
lipodystrophy acquiredSignal413489.7440.6161,892
viral mutation identifiedSignal567368.9338.0175,757
virologic failureSignal778342.9318.6226,684
pathogen resistanceSignal585139.1128.274,949
drug resistanceSignal70957.653.638,308
foetal exposure during pregnancySignal1,62541.439.562,933
drug exposure during pregnancySignal58035.232.518,933
premature babySignal49734.031.215,670
exposure during pregnancySignal58819.417.910,158
treatment failureSignal42010.39.43,527
maternal exposure during pregnancySignal4289.88.93,365
anaemiaSignal6176.66.12,932
pyrexiaSignal3722.22.0241
death3850.90.84
drug ineffective3410.50.5156

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.